Richard Malamut insider trades

Open-market stock purchases and sales by Richard Malamut, Director at Pelthos Therapeutics Inc, from SEC Form 4 filings since Apr 1, 2019.

Recent trades

DateStockTradeValue
Apr 2, 2026PTHS Pelthos Therapeutics IncSold$6.4K
Apr 2, 2026PTHS Pelthos Therapeutics IncSold$6K
Nov 13, 2025PTHS Pelthos Therapeutics IncBought (not open market)—

Companies traded

  • PTHS Pelthos Therapeutics Inc: 2 sales, last Apr 2, 2026
  • CHRO Chromocell Therapeutics Corp: 1 buy, last Nov 13, 2024
  • COLL Collegium Pharmaceutical, Inc: other filings, last Feb 10, 2022

Get free alerts when Richard Malamut files a new trade →